Nancy Ham Sells 400 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) Director Nancy Ham sold 400 shares of the firm's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director now owns 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

U.S. Physical Therapy Stock Up 0.5%

USPH stock traded up $0.40 during midday trading on Monday, hitting $77.40. 264,887 shares of the company's stock were exchanged, compared to its average volume of 117,414. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.20. The firm has a 50 day moving average price of $73.58 and a 200-day moving average price of $81.16. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of 82.34, a price-to-earnings-growth ratio of 3.54 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same period in the previous year, the business earned $0.51 EPS. The business's quarterly revenue was up 18.0% on a year-over-year basis. On average, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.33%. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently made changes to their positions in USPH. Point72 Asset Management L.P. bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $18,886,000. Bahl & Gaynor Inc. increased its holdings in shares of U.S. Physical Therapy by 135.4% in the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock valued at $23,076,000 after acquiring an additional 149,622 shares during the last quarter. Nuveen LLC bought a new stake in shares of U.S. Physical Therapy in the 1st quarter valued at approximately $8,702,000. Raymond James Financial Inc. bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $6,240,000. Finally, Nuveen Asset Management LLC boosted its position in U.S. Physical Therapy by 95.9% during the 4th quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company's stock valued at $10,724,000 after purchasing an additional 59,190 shares during the period.

Wall Street Analysts Forecast Growth

USPH has been the topic of several analyst reports. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research dropped their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. JMP Securities restated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. dropped their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.